Best Billing and Coding Services for Infectious Disease Practices

The appropriate ICD-10-CM code for unspecified osteomyelitis depends on the documented diagnosis and the applicable coding details for the encounter. Because the code set and documentation requirements must be checked against the current official guidelines, practices should verify the diagnosis, site, laterality, and acuity before submitting a claim. Do not select a code from a general description alone.

Coding acute osteomyelitis of the right foot requires the medical record to support the diagnosis, acuity, anatomical site, and laterality. The exact current ICD-10-CM code should be confirmed using the official code set and applicable guidelines before claim submission. Documentation should be reviewed for consistency across the clinical note, diagnosis selection, claim, and any related procedure or drug services.

Available support includes claims management, coding review, claim scrubbing, rejection clearing, denial management, payer-specific appeals, eligibility and authorization support, payment reconciliation, A/R follow-up, credentialing, payer enrollment, contract compliance review, reporting, and revenue-cycle consulting. The services address office visits, hospital consults, infusion, drug claims, specialty drugs, and OPAT workflows where those services apply.

Yes. The available guidance addresses the connected workflow from referral and authorization through first dose, drug acquisition, infusion administration, claims, payment, and collections. It can also help practices examine whether infusion and OPAT services are enrolled, documented, coded, billed, and followed through consistently. Specific reimbursement outcomes remain dependent on payer rules, contracts, documentation, and the practice’s own operating data.

Revenue leakage can be examined through reporting by payer, service line, and provider, together with review of documentation, coding, charge capture, contracts, denials, payment trends, and A/R. The goal is to trace missing or delayed revenue to its source rather than only reviewing final collections. Practices can then prioritize workflow changes using their own figures and claim history.

Yes. Denial support can categorize denials by root cause and prepare payer-specific appeals supported by clinical documentation. Common review areas include drug and administration coding, authorization, medical-versus-pharmacy benefit issues, and under-documented consults. Findings can also be shared with clinical, coding, and front-office teams so recurring problems are addressed in the workflow instead of handled only after denial.

Payment reconciliation compares payments with expected reimbursement for drug, administration, and evaluation and management claims. The review can flag short-pays, incorrect fee schedule application, and unit or NDC mismatches where the records support that analysis. Underpayments can then be disputed and tracked to recovery, while contract and payer patterns can inform future review or renewal discussions.

A practice should consider whether it needs full claims management, overflow assistance, workflow consulting, denial work, A/R follow-up, credentialing, authorization support, or payment review. It should also identify the service lines involved, such as office visits, hospital consults, infusion, specialty drugs, or OPAT. Reviewing current documentation, payer arrangements, claim issues, and internal capacity helps define a practical scope.